chrisvoncsefalvay/vaers-outcomes huggingface dataset:
3/8/21 ED: c/c of SOB x 2 days. Pt c/o diarrhea. Pt states that she received the 2nd pfizer vaccine 2 days ago. O2 at triage was 96% on RA. She was seen in this facility Saturday 3/6/21 for HA. CTA and labs unremarkable. She reports persistent HA, though improved when compared to Saturday. Reports multiple episodes of NB diarrhea. No other medications or treatments tried. In the ER she was seen to have a significant leukocytosis with wbc in 26, AKi with SCr in 2.7, thombocytopenia. Ordered CT scan which showed congestion and LLL pna and trace effusion. ID, Cardiology  and Nephrology consulted. Treated for acute kidney injury with hyposmolar hyponatremia, on tolvactam, Sodium 133, trending up. Treated for sepsis with gram negative bacteremia d/t e.coli, completed ceftriaxone course. Treated for essential hypertension, elevated troponin, BP now controlled. Discharged home on 3/17/21
Patient received his first H1N1 intranasal on 1/5/10 and became sick two days later with fever, vomiting, lethargy, decreased eating and drinking and extreme nausea.
Several months after receiving my second dose, I came down with gout. It was very painful and lasted for several weeks. I have never experienced this before. It was so painful that I went to the hospital. They kept me overnight for observation. I was given two sets of antibiotics and indomethacin (gout medicine). My foot was very painful and I was unable to walk on it. I was given an injection of medication to ease the inflammation. I continued on the medicine for ten days. I went for a f/u with my PCP, and he told me that I should not have been taking indomethacin. He gave me a different medication and the pain went away two weeks later.
I had very strong congestion and sinus symptoms. I also had a sore throat, body aches and a fever, which was 101.9.
Severe arm and shoulder pain.  Unable to raise arm.  Better now but lasted over 2 weeks.  Abnormal pain
Pt received vaccine on march 11, 2021 went into E.R at Hospital and admitted 3/16/2021 Positive COVID-19 Pneumonia
Warm erythematous indurated area 5cmX5cm -treatment - warm soaks
DONOR REPORTS THAT HIS RIGHT AND LEFT HAND/WRISTS BECAME RED AND SWOLLEN 7 DAYS POST VACCINATION. DONOR HAD BILATERAL HAND SUGERY IN 2017. HX OF OSTEOARTHRITIS. DONOR BELIEVES HE MAY HAVE UNDIAGNOSED RA. DONOR WAS SEEN AT CLINIC ON 2/23/23 AND TREATED WITH ORAL STERIODS FOR 5 DAYS; COMPLETED. SYMPTOMS RESOLVED AND NO OTHER COMPLAINTS.
After  the shot I  sat down and waited for 15 minutes and about 12 minutes a felt flushed and my pulse went night around 119 beats per minute and my blood pressure went high to 150 over 99 .. my sugar jumped to 149 and I got so clammy .. it lasted a good 25 minutes I kept checking my o2 and my pulse finally it went down and I was so tired.. I went home and I was fatigue for 5 days .. I don?t know if I should get the second dose after my heart raced
Never felt "right" after receiving vaccine.  Occasional dizziness noted, especially upon standing.   Deterioration in health 5/16/21:   Was on a bicycle ride in the morning and HR monitor read 180 BPM. Rested briefly, did not feel well, rode home.  Continued to not feel well throughout the day. Went to the emergency room at 6:00 PM with irregular HR, fatigue,  and chest tightness. Heart rhythm irregular with ventricular ectopy. Admitted to the hospital, cardiac catherization done 5/17 8:00 AM, no evidence of CAD, diagnosed with non-ischemic cardiomyopathy. No risk factors and all probably causes ruled out.  Non-smoker, healthy lifestyle, no excessive alcohol use.
Information has been received from a nurse practitioner concerning a female infant with allergies to seafood and shellfish who was vaccinated with a dose of MMR II on an unspecified date. There was no concomitant medication. Subsequently the patient experienced a loss of consciousness after received MMR II. The patient's mother relayed that her daughter went limp and her eyes rolled back. Subsequently, the patient recovered fully without requiring treatment on unspecified dates. The patient sought unspecified medical attention. Additional information has been requested.
Information has been received from a healthcare worker referring to multiple unspecified patients. There was no pertinent medical history, concurrent medication or drug allergies/drug reactions reported. On unspecified dates the patient were administered with improperly stored doses of ROTATEQ (lot # L008057, expiration date 01-DEC-2016, oral, dose and frequency unknown). The vaccines were exposed at 61 Fahrenheit (F) for 6 hours and back in range after that. There was no previous temperature excursion. No adverse effects were reported. Additional information has been requested.
Pt developed itching and burning on her neck and chest. Mom gave patient Benadryl and Motrin. This helped the itching but then it came back at noon the next day. Mom gave her more Benadryl. It then came back the following day and Mom gave Benadryl again and then it never came back.
very mild arm pain in his left arm with first vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (very mild arm pain in his left arm with first vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Lot# 039A21A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension (The patient reports that he has High blood pressure for 10 years). Concomitant products included LISINOPRIL for an unknown indication.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (very mild arm pain in his left arm with first vaccine). At the time of the report, PAIN IN EXTREMITY (very mild arm pain in his left arm with first vaccine) outcome was unknown. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The treatment information was not provided.   This case was linked to MOD-2021-114243 (Patient Link).
Patient indicated they have not received a dose of the Pfizer vaccine and was provided a vaccine on 5/28/21. Upon review of records, patient has received a dose of vaccine on 5/19/21.
pt saw files coming through a window; t100.8; tingling in rt leg; mom called MD;
Checked out redness swelling of arm down to elbow started 11/13/2001, only used cold packs.
Left leg (thigh area) has a hard bump and is red around the injection site, and warm to the touch.
He received the vaccine on 04/26 at 5 PM and that day he was fine and he went to bed fine that night. The next morning I couldn't wake him up for school and he was tired, cranky, and I couldn't get him out of bed so he stayed home that day. On 04/28/21 he was  fine and went to school but that night I found him searching for his inhaler and he grabbed the inhaler and went to the bed. On 04/29/21 when I went to wake him up in the morning he was holding his chest and said he hadn't slept the night before because he was having chest pain. I called the pediatrician about 5:30/6:00 AM and they told me to bring him to the ER. Brought him to ER and they did an EKG, blood work, and chest xray. They ruled out blood clot and the chest xray showed that the heart was enlarged and the only thing they noted was that he was still wheezy so they determined that probably the vaccine exacerbated his reactive airway and brought on an asthma attack. He went home with the inhaler, slept that night, and improved. By the time we left the hospital his oxygen levels were fine and he was doing much better.
p/vax pt devel a local rxn that consisted of swelling & cellulitis;
Began experiencing nausea and general stomach pains the morning after receiving the vaccine.  After one day of pain and discomfort I woke the following morning (~44hrs after receiving the vaccine) to extreme acute abdominal pain in the lower right abdomen.  Went to Urgent Care facility and was diagnosed by CT scan as having acute appendicitis.  An emergency appendectomy was scheduled and performed for later that evening.  I stayed at the Hospital overnight on 12/24/2020 post operatively on IV antibiotics to recover from the appendectomy.  Was discharged from the hospital on 12/25/2020 and have been recovering for about 10 days now with limitted activity.
Large erythematous, warm area below injection site measuring about 10 x 8 cm.
LIQUID LEAKING FROM THE INJECTION SITE; This spontaneous report received from a pharmacist concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 18020270, and batch number: 18020270 expiry: UNKNOWN) dose was not reported, administered on 08-MAR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 08-MAR-2021, the subject experienced liquid leaking from the injection site. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from liquid leaking from the injection site. This report was non-serious.
10/25/05 immunization given swelling pain noted per client on 11/02/05 evaluated by FNPC and RN area measured 25mm, indurated, erythema, warm to touch and tender on palpation. Client sent to Family practice for evaluation assessed not to be an abscess, given topical hydrocortisone cream at Clinic as treatment.
The night he received his vaccines (Bivalent, HPV, MCV4, Flu) - he had the chills and back pain. No temperature was taken He was given ibuprofen to help with the pain The next day, his left eye started to become swollen, he noticed it when he woke - both lids were swollen Possible erythema, white part of the eye was red, no pain but a little uncomfortable, there was some tearing, no other discharge He went to the UC that day - was told that it was from the vaccines - given benadryl and antibiotics  Family did not start the otic antibiotics The swelling improved by the time he was seen at the UC and completely resolved in 2 days. The benadryl helped. No swelling at the site of injection of any of the vaccines Minimal pain that resolved in 2 days and did not need treatment No erythema at the site of injections on either arm
Fever for 9 days, throbbing headache for 18 days, joint pain still ongoing, heart palpitations still ongoing, Extreme dizziness and vertigo, sense of extreme pressure in head for several days, coughing and sore throat for 7 days, hot and red skin for 3 days, swelling and pain in right arm although this was mild compared to other symptoms. I?m doing my best to treat with Tylenol, but cannot find a doctor to help with the other symptoms.
Unexplained hyperglycemia with difficult control for several days. Occurred with first and second doses.
Lower-than-authorized dose administered due to medication leaked out of the syringe. Consulted with Dr. and CDC  recommendations for COVID-19 vaccine administration errors and deviations and patient cleared to receive a repeat dose to ensure patient received full dose of vaccine. Patient was educated on this recommendation, patient verbalized understanding and agreed to receive repeat dose.
This is a spontaneous report from a Pfizer-sponsored program comScore Monthly DTC Tracker. A contactable consumer reported similar events for two patients. This is 1st of two reports. An elderly patient of an unspecified gender received PREVNAR 13, via an unspecified route of administration on an unspecified date at single dose for pneumonia. The patient's medical history and concomitant medications were not reported. The patient had the darn pneumonia shots and 5 months later the patient died from pneumonia. Before the patient got the shot the patient was as healthy as can be. The patient died on an unspecified date. It was not reported if an autopsy was performed. No follow-up attempts are possible, information about batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2018378995 same reporter/product/event, different patients; Reported Cause(s) of Death: died from pneumonia; died from pneumonia.
Caught COVID; This spontaneous case was reported by a pharmacist and describes the occurrence of COVID-19 (Caught COVID) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient experienced COVID-19 (Caught COVID). At the time of the report, COVID-19 (Caught COVID) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.  Batch number of the suspect product is unknown.  Around 01-Nov-2021, patient caught COVID and just got out of quarantine yesterday 11-Nov-2021. Patient's second dose of Moderna is scheduled on 18-Nov-2021. The pharmacist wants to know whether patient should be given second shot, or will it be delayed.  This case concerns a 33-year-old male patient without relevant medical history provided, who experienced the unexpected non- serious event of special interest, COVID-19. Reportedly, the event occurred about 10 days after the patient had received the first dose of mRNA-1273 vaccine (the exact start date of event will be requested). The outcome of the event was not specified at the time of this report, and information regarding the clinical course of the event was not provided. The re-challenge cannot be determined as the outcome of the event is unknown at this moment. Based on the current available information, the mRNA-1273 vaccine does not contain a virus capable of causing COVID-19 infection after vaccination, therefore, the causality for COVID-19 is not applicable. The benefit risk relationship of mRNA-1273 is not affected by this report.; Sender's Comments: This case concerns a 33-year-old male patient without relevant medical history provided, who experienced the unexpected non- serious event of special interest, COVID-19. Reportedly, the event occurred about 10 days after the patient had received the first dose of mRNA-1273 vaccine (the exact start date of event will be requested). The outcome of the event was not specified at the time of this report, and information regarding the clinical course of the event was not provided. The re-challenge cannot be determined as the outcome of the event is unknown at this moment. Based on the current available information, the mRNA-1273 vaccine does not contain a virus capable of causing COVID-19 infection after vaccination, therefore, the causality for COVID-19 is not applicable. The benefit risk relationship of mRNA-1273 is not affected by this report.
devel swelling, erythema, warmth 4x6cm area around inj site;also dec use of that arm & c/o pain;resolved in 48-72hr;
fatigue; extreme pain in lower extremities; headache; general feeling of being unwell; This is a spontaneous report from a contactable pharmacist. A 65-year-old male patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 30Mar2021(at the age of 65-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history and concomitant medications. The patient did not had allergy to any medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 31Mar2021, at 23:00 the patient began to experience fatigue, extreme pain in lower extremities, headache, and general feeling of being unwell. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the events fatigue, extreme pain in lower extremities, headache, and general feeling of being unwell were recovered on an unknown date.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Patient had a delayed reaction on her arm that started 7 days after receiving vaccine. Patient reports subtle sensitivity. Reports that it is not itchy but raised. No pain. Reports the rash has become less red and feels as though it is improving. She is also covid positive as of 1/7/2021.
Lost bladder control for couple of hours the night of the shot. Fully recovered the next mornng.
Child's caregiver noticed child had bright red upper arms bilaterally which were warm to the touch.  The child stated that her arms hurt.  The mother brings child to LPH office to let nurse see the arms.  Both of the child's upper arms are red from elbow to shoulder and warm to the touch.   There are scratch marks made by the child at the injection site on the L arm.  Child's temp was 97.8 Tympanic.  The child is very active, mother reports she has a good appetite.  Instructed mother to place ice bags on the arms if the child will tolerate this, also to give Benadryl liquid PO per manfacturers instructions and dose by child's weight. Instructed to put Benadryl cream topically on arms if child continues to scratch at them.
Dry mouth, upset stomach and several bouts of diarrhea. Visit with Doctor on 7/25/14. Monitor diet and adequate fluids. Return to clinic if symptoms worsen.
Pfizer lot EW0178 given to client. Vaccine was beyond the use by date.
Patient was given vaccine after beyond use date on packaging. Patient did not experience any adverse signs or symptoms.
red mark was rectangle/ reaction in his arm/a little red round/ circle is little bigger than the one he got after his second dose; pain; chills; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (red mark was rectangle/ reaction in his arm/a little red round/ circle is little bigger than the one he got after his second dose), PAIN (pain) and CHILLS (chills) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (red mark was rectangle/ reaction in his arm/a little red round/ circle is little bigger than the one he got after his second dose), PAIN (pain) and CHILLS (chills). At the time of the report, ERYTHEMA (red mark was rectangle/ reaction in his arm/a little red round/ circle is little bigger than the one he got after his second dose), PAIN (pain) and CHILLS (chills) outcome was unknown.            No concomitant medications was reported. Treatment medications was not provided.   This case was linked to MOD-2021-142236 (Patient Link).
On 1/31 patient had dyspnea and was covid positive.  He was put on heated high flow oxygen at 60%.  He was intubated on 2/2 and started on Levo and Nimbex.  Doppler studies showed bilateral DVTs in both lower extremities.  Heparin drip started.  Echo showed significant systolic function decrease with Ejection Fraction of 55%.  Chest X-ray showed ground glass opacities and pneumothorax.  3 Chest tubes were placed.  Patient was diagnosed with pseudomonas pneumonia and started on Meropenem.  Patient went into A-fib with RVR requiring cardioversion, amio and levo.  Patient was finally trached and PEG'd on 2/14.  Cardiothoracic surgery consulted for possible need for surgical intervention.  Recent CXR showed no improvement. Scheduled respirator lytics regimen completed.
Pt had rash on face, chest, back, and head, with some burning and itching. Redness.
My tonge started getting sore and swollen a little, started getting small and red ulcers, they feel smooth on some spots, looks like they are trying to heal but never go away. It's been over a year.
Information has been received from a physician concerning a 10 year old female who on an unknown date was vaccinated with a dose of MMR II (route, site, dose and lot number not reported). On 30-Nov-2009 the patient experienced mumps. (the date diagnosed was reported as 20-NOV-2009). The patient was afebrile. Lab results for 20-NOV-2009: IgM was <1:10, IgG was 4.04 and serum amylase was 86. Lab results from 14-DEC-2009 were not reported. The outcome for mumps was not reported. Follow up information has been received from the physician concerning the 10 year old (also reported as 17 year old) female patient who on 26-NOV-2009 experienced mumps (the date diagnosed was reported as 26-NOV-2009). The patient was afebrile and presented left parotitis. At the time of the report, the outcome of the patient was unknown. No further information is available.
minor soreness at the injection site; This spontaneous case was reported by a health care professional and describes the occurrence of VACCINATION SITE PAIN (minor soreness at the injection site) in a 74-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced VACCINATION SITE PAIN (minor soreness at the injection site). At the time of the report, VACCINATION SITE PAIN (minor soreness at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Rapid heartbeat for approximately 2 hours; also slight fever, headache, body aches for approximately 6-8 hours.  Provided OTC Motrin for headache. By 11/2/2009 runny nose and slight cough had developed, which got worse throughout the week in terms of nasal congestion and hacking cough.
Syncope; This spontaneous report was received from a pharmacist via company representative refers to a 15-year-old male patient. The patient's medical history, drug reactions/allergies and concomitant medications were not reported. On an unknown date, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) (dosing details, route, lot # and expiration date were not reported) for prophylaxis. On an unknown date, the patient experienced syncope post administration of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9). The outcome of syncope was unknown. Reporters causality assessment was not reported. There was no product quality complaint associated with this report.     Upon internal review the event syncope was determined to be medically significant.